Journal Article
. 2021 Feb;().
doi: 10.1007/s10120-021-01155-y.

Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer

In-Seob Lee 1 Divya Sahu 1 Hoon Hur 2 Jeong-Hwan Yook 3 Byung-Sik Kim 3 Ajay Goel 4 
  • PMID: 33523340
  •     35 References


Background: Diffuse type gastric cancer (DGC), represented by low sensitivity to chemotherapy and poor prognosis, is a heterogenous malignancy in which patient subsets exhibit diverse oncological risk-profiles. This study aimed to develop molecular biomarkers for robust prognostic risk-stratification and improve survival outcomes in patients with diffuse type gastric cancer (DGC).

Methods: We undertook a systematic and comprehensive discovery and validation effort to identify recurrence prediction biomarkers by analyzing genome-wide transcriptomic profiling data from 157 patients with DGC, followed by their validation in 254 patients from 2 clinical cohorts.

Results: Genome-wide transcriptomic profiling identified a 7-gene panel for robust prediction of recurrence in DGC patients (AUC = 0.91), which was successfully validated in an independent dataset (AUC = 0.86). Examination of 180 specimens from a training cohort allowed us to establish a gene-based risk prediction model (AUC = 0.78; 95% CI 0.71-0.84), which was subsequently validated in an independent cohort of 74 GC patients (AUC = 0.83; 95% CI 0.72-0.90). The Kaplan-Meier analyses exhibited a consistently superior performance of our risk-prediction model in the identification of high- and low-risk patient subgroups, which was significantly improved when we combined our gene signature with the tumor stage in both clinical cohorts (AUC of 0.83 in the training cohort and 0.89 in the validation cohort). Finally, for an easier clinical translation, we established a nomogram that robustly predicted prognosis in patients with DGC.

Conclusions: Our novel transcriptomic signature for risk-stratification and identification of high-risk patients with recurrence could serve as an important clinical decision-making tool in patients with DGC.

Keywords: Biomarker; Diffuse type; Gastric cancer; Recurrence; Transcriptomic.

HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells.
Shu Chen, Yang Wang, +2 authors, Xiaofang Sheng.
Biomed Pharmacother, 2016 Oct 25; 83. PMID: 27522003
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, +5 authors, F Bray.
Int J Cancer, 2018 Oct 24; 144(8). PMID: 30350310
Highly Cited.
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Yung-Jue Bang, Young-Woo Kim, +15 authors, CLASSIC trial investigators.
Lancet, 2012 Jan 10; 379(9813). PMID: 22226517
Highly Cited.
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.
Shinichi Sakuramoto, Mitsuru Sasako, +12 authors, ACTS-GC Group.
N Engl J Med, 2007 Nov 06; 357(18). PMID: 17978289
Highly Cited.
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
David Cunningham, William H Allum, +13 authors, MAGIC Trial Participants.
N Engl J Med, 2006 Jul 11; 355(1). PMID: 16822992
Highly Cited.
Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Jae-Ho Cheong, Han-Kwang Yang, +19 authors, Sung Hoon Noh.
Lancet Oncol, 2018 Mar 24; 19(5). PMID: 29567071
Highly Cited.
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.
Sang Cheul Oh, Bo Hwa Sohn, +35 authors, Ju-Seog Lee.
Nat Commun, 2018 May 05; 9(1). PMID: 29725014    Free PMC article.
Highly Cited.
Acta Pathol Microbiol Scand, 1965 Jan 01; 64. PMID: 14320675
Highly Cited.
Clinical impact of tumour biology in the management of gastroesophageal cancer.
Florian Lordick, Yelena Y Janjigian.
Nat Rev Clin Oncol, 2016 Mar 02; 13(6). PMID: 26925958    Free PMC article.
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.
Razvan Cristescu, Jeeyun Lee, +31 authors, Amit Aggarwal.
Nat Med, 2015 Apr 22; 21(5). PMID: 25894828
Highly Cited.
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.
Bo Hwa Sohn, Jun-Eul Hwang, +18 authors, Ju-Seog Lee.
Clin Cancer Res, 2017 Jul 28;. PMID: 28747339    Free PMC article.
Highly Cited.
Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing.
Swee Seong Wong, Kyoung-Mee Kim, +23 authors, Amit Aggarwal.
Nat Commun, 2014 Nov 20; 5. PMID: 25407104
Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells.
T-Y Jeon, M-E Han, +11 authors, S-O Oh.
Br J Cancer, 2010 Jan 21; 102(4). PMID: 20087351    Free PMC article.
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.
Tetsuya Ueda, Stefano Volinia, +14 authors, Carlo M Croce.
Lancet Oncol, 2009 Dec 22; 11(2). PMID: 20022810    Free PMC article.
Highly Cited.
Reporting recommendations for tumor marker prognostic studies (REMARK).
Lisa M McShane, Douglas G Altman, +4 authors, Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.
J Natl Cancer Inst, 2005 Aug 18; 97(16). PMID: 16106022
Highly Cited.
[WHO Classification of digestive tumors: the fourth edition].
Jean-François Fléjou.
Ann Pathol, 2011 Nov 30; 31(5 Suppl). PMID: 22054452
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.
Stephen B Edge, Carolyn C Compton.
Ann Surg Oncol, 2010 Feb 25; 17(6). PMID: 20180029
Highly Cited.
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.
Nan Song, Katherine L Pogue-Geile, +9 authors, Soonmyung Paik.
JAMA Oncol, 2016 Jun 09; 2(9). PMID: 27270348    Free PMC article.
A proteomic landscape of diffuse-type gastric cancer.
Sai Ge, Xia Xia, +36 authors, Jun Qin.
Nat Commun, 2018 Mar 10; 9(1). PMID: 29520031    Free PMC article.
Highly Cited.
Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review).
Dali Chen, Guowei Che.
Oncol Lett, 2014 Sep 10; 8(4). PMID: 25202343    Free PMC article.
Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders.
Isabelle Mercier, Jean-Francois Jasmin, +6 authors, Michael P Lisanti.
Lab Invest, 2009 Apr 01; 89(6). PMID: 19333235    Free PMC article.
Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes.
Yoshiyuki Watanabe, Hyun Soo Kim, +12 authors, Jean-Pierre J Issa.
Gastroenterology, 2009 Apr 21; 136(7). PMID: 19375421    Free PMC article.
Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.
Honor Hugo, M Leigh Ackland, +4 authors, Erik W Thompson.
J Cell Physiol, 2007 Aug 08; 213(2). PMID: 17680632
Highly Cited. Review.
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Ke-Feng Lei, Bing-Ya Liu, +4 authors, Zheng-Gang Zhu.
Exp Ther Med, 2012 Sep 13; 3(1). PMID: 22969854    Free PMC article.
The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis.
Hui Li, Anjing Zhong, +4 authors, Maode Lai.
Sci Rep, 2017 Jul 09; 7(1). PMID: 28687755    Free PMC article.
Differential expression and prognostic role of selected genes in colorectal cancer patients.
Pavel Pitule, Ondrej Vycital, +7 authors, Vaclav Liska.
Anticancer Res, 2013 Nov 14; 33(11). PMID: 24222123
Visinin-like protein-1 overexpression is an indicator of lymph node metastasis and poor prognosis in colorectal cancer patients.
Tomonori Akagi, Naoki Hijiya, +3 authors, Seigo Kitano.
Int J Cancer, 2011 Nov 05; 131(6). PMID: 22052372
Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake.
Yun Zhu, Peizhong Peter Wang, +10 authors, Patrick S Parfrey.
BMC Cancer, 2018 Feb 08; 18(1). PMID: 29409465    Free PMC article.
The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Sascha Abbas, Jakob Linseisen, +4 authors, Jenny Chang-Claude.
Cancer Epidemiol Biomarkers Prev, 2008 Jun 19; 17(6). PMID: 18559548
Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR/NF-κb signaling.
Jiarong Chen, Aibin Liu, +25 authors, Yanming Huang.
Cancer Lett, 2020 Apr 15; 482. PMID: 32289442
Critical Modulation of Hematopoietic Lineage Fate by Hepatic Leukemia Factor.
Martin Wahlestedt, Vasileios Ladopoulos, +9 authors, David Bryder.
Cell Rep, 2017 Nov 23; 21(8). PMID: 29166614    Free PMC article.